凭借明星GLP-1药物,礼来公司2025年第一季度迎来业绩开门红,但由于下调全年每股收益指引,美股盘前下跌明显。5月1日,美国礼来公司(LLY.US)发布2025年一季报,第一季度营收127.29亿美元,同比增长45%,超出市场预期;净利润27.59亿美元,同比增长23%;非GAAP标准下净利润30.04亿美元,同比增长29%;每股收益3.34美元,同比增长29%。礼来第一季度业绩从地区来看,礼来...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.